Business
Corporate Mergers Market Capitalization Medical Technology Pharmaceutical Sciences Monopoly Prevention Broadcasting Telecom Companies Genetic Research Privacy Issues Corporate Restructuring
The deal grants President Trump veto rights over corporate moves in return for a mandated $11 billion U.S. investment by 2028.